Multi-Laboratory Evaluation of Prototype Dried Blood Spot Quality Control Materials for Creatine Kinase-MM Newborn Screening Assays
Paul Dantonio(Centers for Disease Control and Prevention), Robert F. Vogt(Centers for Disease Control and Prevention), Konstantinos Pétritis(Centers for Disease Control and Prevention), Sunju Park(Johns Hopkins University), Elizabeth McCown(Centers for Disease Control and Prevention), Natalie Street(Centers for Disease Control and Prevention), Timothy Lim(Centers for Disease Control and Prevention), Norma P. Tavakoli(New York State Department of Health), Michele Caggana(New York State Department of Health), Brooke Migliore(RTI International), H. Phan(Rare Disease Therapeutics (United States)), Katerina S. Kucera(RTI International)
Cited by 4
Related Papers
Evidence‐based path to newborn screening for duchenne muscular dystrophy
|Annals of Neurology|2012|816
Use of Artificial Neural Networks for the Accurate Prediction of Peptide Liquid Chromatography Elution Times in Proteome Analyses
|Analytical Chemistry|2003|295
Application of Peptide LC Retention Time Information in a Discriminant Function for Peptide Identification by Tandem Mass Spectrometry
|Journal of Proteome Research|2004|143
Development and Evaluation of Quality Control Dried Blood Spot Materials in Newborn Screening for Lysosomal Storage Disorders
|Clinical Chemistry|2008|133
Newborn screening for X-linked adrenoleukodystrophy in New York State: Diagnostic protocol, surveillance protocol and treatment guidelines
|Molecular Genetics and Metabolism|2015|124